title: Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence.
authors.affiliation: Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: DDawson@mednet.ucla.edu.
authors.forename: David W
authors.initials: DW
authors.lastname: Dawson
authors.affiliation: Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
authors.forename: Martin E
authors.initials: ME
authors.lastname: Fernandez-Zapico
mesh_terms: D000964:Antimetabolites, Antineoplastic; D045744:Cell Line, Tumor; D003841:Deoxycytidine / Q000031:analogs & derivatives; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects; D009364:Neoplasm Recurrence, Local; D010190:Pancreatic Neoplasms; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine